Kymanox Executive Advisors
Whether you are a C-Suite executive requiring support on overall business strategy and program development or a member of a board looking for additional leadership support, Kymanox Executive Advisors are seasoned executives who have deep expertise in the life sciences industry, bringing products from inception through commercialization.
01
Strategy
We provide our clients with expert strategic guidance to maximize success in the following areas: business start-up, scale-up and organizational growth, operations and commercialization, human factors and regulatory affairs, connected and digital health, drug/device combination product development, and intellectual property development.
02
Key Industry Partnerships
Our Kymanox Executive Advisors (KEAs) have deep ties and connections throughout the industry. We can provide warm introductions in order to facilitate potential collaborations and work alongside your team to provide recommendations with respect to strategic partnership opportunities.
03
Combination Product Expertise
We have deep experience with the development and commercialization of drug/device combination products. Our KEAs understand the complexity involved and can provide strategic advice and oversight to ensure program success. This includes supporting negotiation and expectations with proper Contract Development and Manufacturing Organization (CDMO) selection as well as business risk mitigation as a result of challenges faced during development.
04
Expert Networks
We ensure you have the right experts to support you during all phases of development. KEAs can point you in the right direction and facilitate engagement with technical experts or other consultants that we know provide the right guidance and specialized services based on our strong relationships in the life science Industry.
Meet Our Kymanox Executive Advisors
Fran DeGrazio
KYMANOX EXECUTIVE ADVISOR
Executive Leadership
Our seasoned executives have not only built and led companies and are recognized as leaders in their field, but have also successfully developed products from inception through commercialization.
Executive-level leaders are true experts in their fields driving strategies around combination products, product development, primary packaging, parenterals, drug delivery, connected devices, contract manufacturing, product strategy, business intelligence, competitive landscape, technical assessments, business case evaluations, CMO selection and assessments, and regulatory success assessments.
Helpful Links
Markets That Benefit from Kymanox Executive Advisors
Drug Combination Products
Our experts understand the interaction between devices and drug products. Our experience includes injectables, nasal, respiratory, and more.
Biologics and Cell & Gene Therapy Services
We understand why “the product is the process” and how to implement solutions to your unique challenges.
Frequently Asked KEA Questions (FAQs)
How do I engage with the KEA team?
Please contact Michael Denzer, our VP of Technical Solutions at michael.denzer@kymanox.com. Engagements are flexible and right-fit to your needs.
How much does engagement with Kymanox Executive Advisors cost?
Each engagement is customized based on your need, the duration of work, and the KEA(s) being utilized. We will provide a customized Statement of Work (SOW) after an initial call to determine how we can help.
Why should I contact Michael Denzer rather than just reach out to KEA members directly?
Michael will guide you to the best solution for your particular needs. As an industry veteran and having deep knowledge of all Kymanox’ capabilities, he can ensure you have the right KEA solution.
Read the Latest at Kymanox
Kymanox Announces First Kymanox Executive Advisor: Fran DeGrazio
Accomplished Life Science Executives Supporting Biopharma Strategy
Friday, 12 August 2022
Philadelphia, Pennsylvania and Morrisville, North Carolina, USA
Kymanox Corporation (“Kymanox”), a professional services provider e...
Kymanox Announces First Fellow Position
New Position of Honor for Distinguished Kymanox Clinical and Regulatory, Affairs Lead
Thursday, 28 July 2022
Boston, Massachusetts and Morrisville, North Carolina, USA
Kymanox Corporation (“Kymanox”), a professional servic...
Analytical Techniques For Addressing Viral Vector Purification Challenges
When producing gene therapies, circular plasmids containing therapeutic DNA, an outer capsid shell, and proteins required for virus assembly are inserted into host cells. Manufacturers often face difficulties creating consistency in gene therapy produc...